Study Finds Women With Autoimmune Conditions More Likely to Face Misdiagnosis as Psychological

Women suffering from autoimmune conditions are significantly more likely than men to have their symptoms dismissed as psychological or psychosomatic, according to new research. The study, conducted by the University of Cambridge and the University of East Anglia, reveals a concerning gender disparity in the diagnosis and treatment of autoimmune diseases.

Autoimmune conditions affect approximately one in 10 people worldwide, impacting hundreds of millions globally. These disorders, where the immune system mistakenly attacks healthy tissue, can lead to a variety of symptoms including fatigue, muscle pain, and skin rashes. However, the research highlights that women face particular challenges in receiving accurate diagnoses.

The study, published in the Lancet eClinicalMedicine journal, analyzed data from over 6,600 individuals with autoimmune conditions, predominantly female patients from the UK. Results show that 43% of women reported being told their condition was psychiatric in origin, compared to 33% of men. Additionally, 34% of women had their symptoms misdiagnosed as psychosomatic, versus 22% of men.

After adjusting for variables such as age, disease type, geographic location, and socioeconomic status, researchers determined that women were 46% more likely to receive a psychiatric misdiagnosis and 74% more likely to be told their symptoms were psychosomatic compared to men.

Women also experienced significantly longer delays in diagnosis. While men typically received a diagnosis within three months of symptom onset, women often waited between one to two years. This delay in proper diagnosis translates to prolonged periods without appropriate treatment.

The most common conditions among female participants included autoimmune thyroid disease, such as Hashimoto’s disease and Graves’ disease, which affects the thyroid gland’s function. Systemic lupus was reported in one out of every seven women in the study. For male participants, rheumatoid arthritis, vasculitis, and antiphospholipid syndrome were the most frequently reported conditions.

Melanie Sloan, the lead author and researcher at both institutions, emphasized the lasting impact of such misdiagnoses. “The damage caused to women by these types of misdiagnosis can be very long lasting in terms of trusting doctors and their own self-esteem,” she noted.

The research team acknowledged that diagnostic challenges exist for both genders but pointed out that women face additional obstacles. “Historical biases in medicine may persist, including positioning females as less credible and emotional reporters of symptoms than males,” the researchers observed.

Sloan highlighted the importance of avoiding premature psychological explanations for symptoms. “It is really important that symptoms are not automatically assumed to be psychological and for doctors to just say, ‘I believe you,’ to patients with symptoms that the doctors cannot see.”

Shaista Tayabali, a study co-author and patient with an autoimmune condition, reinforced these findings. “The differences between the sexes in misdiagnoses for people with autoimmune diseases is stark. The fact that females reported higher rates of psychiatric and psychosomatic misdiagnoses than males … suggests that historical gender biases remain a challenging aspect of the diagnostic journey.”

“Although labels such as hysteria are outdated, and fortunately rarely used nowadays, as women we still often have a harder time having our symptoms believed and therefore addressed accurately,” Tayabali added.

The findings underscore the need for increased awareness and training among healthcare providers to address gender bias in medical diagnosis, ensuring that all patients receive appropriate care regardless of sex.

Source link